Substituted pyridinones as modulators of p38 map kinase

Details for Australian Patent Application No. 2003217433 (hide)

Owner Pharmacia Corporation

Inventors Blevis-Bal, Radhika M; Naing, Win; Hickory, Brian S; MADSEN, Heather, M.; Sambandam, Aruna; Walker, John; Alvira, Edgardo; Shieh, Huey S; Durley, Richard C; Promo, Michele A; Boehm, Terri L; XIng, Li; Devraj, Rajesh; Liu, Shuang; Selness, Shaun R; Owen, Thomas; Scott, Ian L; Rucker, Paul V; Hitchcock, Jeff; Devadas, Balekudru; McGee, Kevin F; Jerome, Kevin D; Marrufo, Laura D

Agent Spruson & Ferguson

Pub. Number AU-B-2003217433

PCT Number PCT/US03/04634

PCT Pub. Number WO2003/068230

Priority 60/436,915 30.12.02 US; 60/357,029 14.02.02 US

Filing date 14 February 2003

Wipo publication date 4 September 2003

Acceptance publication date 8 March 2007

International Classifications

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/4725 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/436,915 30.12.02 US; 60/357,029 14.02.02 US

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2003217433

8 March 2007 Application Accepted

  Published as AU-B-2003217433

5 July 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003217434-GLOBAL CONSOLIDATED CLEARANCE METHODS AND SYSTEMS

2003217432-ANGIOPOIETIN-1 IN THE TREATMENT OF DISEASE